Bryan A. Liang

National University of Singapore — Singapore

Health Professions · Health Sciences

35h-index4.4kcitations311works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Malpractice and Liability Issues(86), Pharmaceutical Economics and Policy(48), Pharmaceutical industry and healthcare(40), Patient Safety and Medication Errors(35), Pharmaceutical Quality and Counterfeiting(30)

Publications311 total

Big Data Analytics for Optimizing Film Distribution and Social Media Promotion
2025
SECA: Semantically Equivalent and Coherent Attacks for Eliciting LLM Hallucinations
ArXiv.org·2025Open Access
Perceptions of Nurses and Nursing Students Regarding Evidence‐Based Nursing: A Qualitative Systematic Review
Journal of Advanced Nursing·2025· 1 citedOpen Access
LB1071 Differentiation and proteomic insights into psoriasis and TNFi-induced psoriatic dermatitis in pediatric patients
Journal of Investigative Dermatology·2025Open Access
Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies
The Journal of Rheumatology·2025
KDA: A Knowledge-Distilled Attacker for Generating Diverse Prompts to Jailbreak LLMs
arXiv (Cornell University)·2025Open Access
Combinatorial Wnt signaling determines wing margin color patterns of the swallowtail butterfly ground plan
2024· 3 citedOpen Access
Assessing Characteristics and Compliance of Online Delta-8 Tetrahydrocannabinol Product Sellers
Cannabis and Cannabinoid Research·2023· 5 citedOpen Access
Liability Before Diagnosis: Failure to Admit in a Stroke Case
Stroke·2023Open Access
Understanding Medical Malpractice Lawsuits
Stroke·2023· 6 citedOpen Access
Big Data, Natural Language Processing, and Deep Learning to Detect and Characterize Illicit COVID-19 Product Sales: Infoveillance Study on Twitter and Instagram
JMIR Public Health and Surveillance·2020· 120 citedOpen Access
An Analysis of China Health Charity Credibility Before and After the 2016 Charity Law of the People’s Republic of China
Asian Journal of Criminology·2020· 1 cited
Machine Learning to Detect Self-Reporting of Symptoms, Testing Access, and Recovery Associated With COVID-19 on Twitter: Retrospective Big Data Infoveillance Study
JMIR Public Health and Surveillance·2020· 155 citedOpen Access
Big Data, Natural Language Processing, and Deep Learning to Detect and Characterize Illicit COVID-19 Product Sales: Infoveillance Study on Twitter and Instagram (Preprint)
2020· 4 citedOpen Access
Machine Learning to Detect Self-Reporting of Symptoms, Testing Access, and Recovery Associated With COVID-19 on Twitter: Retrospective Big Data Infoveillance Study (Preprint)
2020· 2 citedOpen Access
Themes for a System of Medical Error Disclosure: Promoting Patient Safety using a Partnership of Provider and Patient
2017
In Reply—Electronic Health Records and Drugs Prescribed for Off-label Indications
Mayo Clinic Proceedings·2017Open Access
Health Advertising in the Digital Age
2017· 3 cited
After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?
Mayo Clinic Proceedings·2016· 2 cited
Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies
Journal of Health Communication·2016· 14 cited
page 1 of 16Next →

Frequent Co-authors

Tim K. Mackey(32), Richard W. Hartel(6), Raphael Cuomo(4), Vidya Purushothaman(2), Jiawei Li(2), Neal Shah(2), Matthew Nali(2), Cortni Bardier(2), Mingxiang Cai(2), Yanjun Shi(2), Justin A. Zivin(2), Kimberly M. Lovett(2), Ryan Hafen(1), Kimberly C. Brouwer(1), Daniel E. Lee(1), John T. Contreras(1), Peter York(1), Thomas T Kubic(1), Yuping Shi(1), Hong Jiang(1)